Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care
11:27am, Tuesday, 04'th Feb 2025
New survey shows 40% of people living with diabetes have skipped or missed a doctor's appointment due to shame or stigma1 70% of people with diabetes said supportive comments from others can significa
2 Unstoppable Dividend Stocks That Will Pay You for Life
07:45am, Monday, 03'rd Feb 2025
In the past few years, some high-profile dividend stocks have reduced their payouts, much to the chagrin of investors. As most income seekers want to avoid this fate, they might consider turning to ar
My Best Dividend Aristocrats For February 2025
03:11am, Wednesday, 29'th Jan 2025
The ProShares S&P 500 Dividend Aristocrat ETF posted its 3rd worst monthly return in December, falling by 7.69%. I present 3 strategies that can theoretically beat the dividend aristocrat index in the
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
10:00am, Tuesday, 28'th Jan 2025
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Reasons to Retain ABT Stock in Your Portfolio Now
07:21am, Tuesday, 28'th Jan 2025
Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.
Expanding EPD Business Supports ABT Stock Amid Macro Issues
12:35pm, Monday, 27'th Jan 2025
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Is There More Upside For ABT Stock After A 10% Jump In A Week?
06:00am, Monday, 27'th Jan 2025
Abbott (NYSE: ABT) recently reported its Q4 results, with revenues marginally below and earnings meeting the street expectations. The company reported revenue of $10.97 billion and earnings of $1.34 o
Abbott Laboratories: Strong Q4 Results And Bullish Outlook
03:27pm, Sunday, 26'th Jan 2025
On January 22, Abbott Laboratories published financial results for the fourth quarter of 2024, initially receiving mixed reactions from Wall Street. However, its revenue was about $10.97 billion for t
Abbott Laboratories Will Outperform Healthcare Stocks in 2025
07:18am, Friday, 24'th Jan 2025
The outlook and technical action suggest Abbott Laboratories NYSE: ABT will lead healthcare names like Johnson & Johnson NYSE: JNJ higher in 2025. While each produced a solid quarter, Abbott Laborato
What Can The Dividend Kings Deliver In 2025?
03:14am, Friday, 24'th Jan 2025
The Dividend Kings underperformed the broad U.S. equity market in 2024, achieving a 5.53% total return compared to the S&P 500's 24.89%. 2024 returns for the Dividend Kings were primarily driven by ea
Why Is Abbott Stock Trading Higher On Thursday?
03:01pm, Thursday, 23'rd Jan 2025
On Wednesday, Abbott Laboratories ABT reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion.
Two Contrarian Dividends With Triple-Digit Potential For Trump 2.0
12:48pm, Thursday, 23'rd Jan 2025
Tariff Day has left us with Canada and Mexico in the crosshairs. With North American trade in focus, this may actually give a respite to stocks with supply chains elsewhere and light a fire under them
Abbott Laboratories: Now Back In The Buy Zone (Rating Upgrade)
08:30am, Thursday, 23'rd Jan 2025
Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month. The company looks set up to deliver double-digit annual adjusted diluted E
My Top 5 Stocks to Buy in Early 2025
04:15am, Thursday, 23'rd Jan 2025
It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in 2025 and over the long term. The healthcare space is a great place to look for
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales
02:39pm, Wednesday, 22'nd Jan 2025
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 250 points on Wednesday.
